Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal

Por Annaházi, Anita, Molnár, Tamás
Publicado no Gastroenterol Res Pract (2015)

Role of antispasmodics in the treatment of irritable bowel syndrome

Por Annaházi, Anita, Róka, Richárd, Rosztóczy, András, Wittmann, Tibor
Publicado em 2014

Luminal Cathepsin G and Protease-Activated Receptor 4 : A Duet Involved in Alterations of the Colonic Epithelial Barrier in Ulcerative Colitis

Por Dabek, Marta, Ferrier, Laurent, Roka, Richard, Gecse, Krisztina, Annahazi, Anita, Moreau, Jacques, Escourrou, Jean, Cartier, Christel, Chaumaz, Gilles, Leveque, Mathilde, Ait-Belgnaoui, Afifa, Wittmann, Tibor, Theodorou, Vassilia, Bueno, Lionel
Publicado em 2009

A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer

Por Annaházi, Anita, Ábrahám, Szabolcs, Farkas, Klaudia, Rosztóczy, András, Inczefi, Orsolya, Földesi, Imre, Szűcs, Mónika, Rutka, Mariann, Theodorou, Vassilia, Eutamene, Helene, Bueno, Lionel, Lázár, György, Wittmann, Tibor, Molnár, Tamás, Róka, Richárd
Publicado no Br J Cancer (2016)

Anti-Hu antibodies activate enteric and sensory neurons

Por Li, Qin, Michel, Klaus, Annahazi, Anita, Demir, Ihsan E., Ceyhan, Güralp O., Zeller, Florian, Komorowski, Lars, Stöcker, Winfried, Beyak, Michael J., Grundy, David, Farrugia, Gianrico, De Giorgio, Roberto, Schemann, Michael
Publicado no Sci Rep (2016)